J Uriach Y Compania SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:J Uriach Y Compania SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013216
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
J Uriach Y Compania SA (Uriach) is a pharmaceutical company that offers food supplements, cosmetics and OTC products. It also researches, develops and manufactures active ingredients for the pharmaceutical market. Uriach provides antiflatulents, antifungals, mineral supplements and antiplatelet drugs among others. The company offers its products in the form of tablets, powders, capsules, pills, granules, creams and ointments. It also provides contract manufacturing services. Uriach spans its expertise in the development and marketing of generic files for international licensing. It offers products for sleep and relaxation, skin and beauty, energy and sport, irritation and wounds and others. Uriach is headquartered at Barcelona, Spain.

J Uriach Y Compania SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
J Uriach Y Compania SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 10
Licensing Agreements 12
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 12
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 13
Asset Transactions 14
Actavis Acquires Worldwide Rights To Albaconazole From Palau Pharma 14
Palau Pharma Sells UR-65318 To US Pharma Company 15
Draconis Pharma Acquires Drug Discovery Unit Of Palau Pharma 16
Acquisition 17
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach 17
J Uriach Y Compania SA – Key Competitors 18
J Uriach Y Compania SA – Key Employees 19
J Uriach Y Compania SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
May 11, 2016: Uriach grows by 10% in 2015, reinforcing its status as a reference for financial performance in the pharmaceutical sector 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Key Facts 2
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
J Uriach Y Compania SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
J Uriach Y Compania SA, Deals By Therapy Area, 2011 to YTD 2017 8
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 10
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 12
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 13
Actavis Acquires Worldwide Rights To Albaconazole From Palau Pharma 14
Palau Pharma Sells UR-65318 To US Pharma Company 15
Draconis Pharma Acquires Drug Discovery Unit Of Palau Pharma 16
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach 17
J Uriach Y Compania SA, Key Competitors 18
J Uriach Y Compania SA, Key Employees 19
J Uriach Y Compania SA, Other Locations 20
J Uriach Y Compania SA, Subsidiaries 20

★海外企業調査レポート[J Uriach Y Compania SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acceleron Pharma Inc (XLRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Acceleron Pharma Inc (Acceleron Pharma) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics to treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodys …
  • Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Ineos Group AG-石油・ガス分野:企業M&A・提携分析
    Summary Ineos Group AG (Ineos) is a chemical company, which manufactures and sells petrochemicals, specialty chemicals and oil products. The company’s products include engineering thermoplastic resins, chlor-alkali chemicals, PVC products, films and compounds; and melamine resins for coating, specia …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Jack Henry & Associates, Inc.:企業の戦略・SWOT・財務情報
    Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Its I'm InTouch provides a secure and easy to use PC remote access softw …
  • CMI Ltd (CMI):企業の財務・戦略的SWOT分析
    CMI Ltd (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Tullow Oil Plc (TLW):石油・ガス:M&Aディール及び事業提携情報
    Summary Tullow Oil Plc (Tullow) is an independent upstream oil and gas company. It explores for, develops and produces oil and natural gas in Africa and South America. The company has licenses, both onshore and offshore, across Africa, and offshore exploration licenses in Guyana, Suriname, Uruguay, …
  • BICE Vida Compania de Seguros S.A.:企業の戦略・SWOT・財務情報
    BICE Vida Compania de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary BICE Vida Compania de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Jones Lang LaSalle Inc (JLL):企業の財務・戦略的SWOT分析
    Jones Lang LaSalle Inc (JLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • National Gypsum Co:企業の戦略・SWOT・財務情報
    National Gypsum Co - Strategy, SWOT and Corporate Finance Report Summary National Gypsum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Princeton University:製薬・医療:M&Aディール及び事業提携情報
    Summary Princeton University (Princeton) is an education service provider that offers undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It offers services such as health services, event planning, exte …
  • W&T Offshore Inc (WTI):石油・ガス:M&Aディール及び事業提携情報
    Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospects …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company's pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascula …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • Lantheus Medical Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Southwire Company, LLC:企業の戦略・SWOT・財務情報
    Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Grupo Catalana Occidente, S.A.:戦略・SWOT・企業財務分析
    Grupo Catalana Occidente, S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Catalana Occidente, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oval Medical Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd is a medical device company that develops revolutionary autoinjectors. The company designs and develops drug delivery devices and drug delivery solutions. Its technologies are used to deliver viscous formulations and sensi …
  • National Fuel Gas Company:企業の戦略・SWOT・財務情報
    National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report Summary National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆